• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

4.370 -0.460 (-9.52%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 983,472
Open 4.910
Bid (Size) 4.200 (400)
Ask (Size) 4.730 (700)
Prev. Close 4.830
Today's Range 4.200 - 4.990
52wk Range 0.2404 - 5.120
Shares Outstanding 17,472,986
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Relmada Therapeutics Inc (NASDAQ:RLMD) Reports Wider-Than-Expected Q3 2025 Loss ↗
November 13, 2025
Relmada Therapeutics posts a wider-than-expected Q3 2025 loss, but reports strong 92% response rate for its bladder cancer drug NDV-01. 
Via Chartmill
News headline image
Relmada (RLMD) Q3 2025 Earnings Call Transcript ↗
November 13, 2025
Relmada (RLMD) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
N/A
N/A
1 Month
+9.3%
+9.3%
3 Month
+110.1%
+110.1%
6 Month
+616.2%
+616.2%
1 Year
+829.6%
+829.6%

More News

Read More
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Via Benzinga
News headline image
A Glimpse of Relmada Therapeutics's Earnings Potential ↗
November 12, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
November 04, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
October 06, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 12, 2025 ↗
May 12, 2025
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
October 03, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 03, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
September 04, 2025
Via Benzinga
News headline image
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
September 03, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 02, 2025
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-08-29: top gainers and losers in today's session. ↗
August 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
August 29, 2025
Via Benzinga
News headline image
Top movers in Friday's session ↗
August 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
August 29, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
August 28, 2025
Via Benzinga
News headline image
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket ↗
July 22, 2025
Via Benzinga
News headline image
Tuesday's session: top gainers and losers ↗
April 29, 2025
Via Chartmill
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
April 29, 2025
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Tuesday's session. ↗
April 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
April 29, 2025
Via Benzinga
News headline image
These stocks are gapping in today's session ↗
April 29, 2025
Via Chartmill
News headline image
Top movers in Tuesday's pre-market session ↗
April 29, 2025
Via Chartmill

Frequently Asked Questions

Is Relmada Therapeutics, Inc. - Common Stock publicly traded?
Yes, Relmada Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Relmada Therapeutics, Inc. - Common Stock trade on?
Relmada Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Relmada Therapeutics, Inc. - Common Stock?
The ticker symbol for Relmada Therapeutics, Inc. - Common Stock is RLMD on the Nasdaq Stock Market
What is the current price of Relmada Therapeutics, Inc. - Common Stock?
The current price of Relmada Therapeutics, Inc. - Common Stock is 4.370
When was Relmada Therapeutics, Inc. - Common Stock last traded?
The last trade of Relmada Therapeutics, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Relmada Therapeutics, Inc. - Common Stock?
The market capitalization of Relmada Therapeutics, Inc. - Common Stock is 76.36M
How many shares of Relmada Therapeutics, Inc. - Common Stock are outstanding?
Relmada Therapeutics, Inc. - Common Stock has 76M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap